Long-term changes and variability in diabetes risk factors prior to the development of impaired glucose homeostasis

Diabetic Medicine

Volumn 24, Issue 11, 2007, Pages 1269-1278

  Laspa, E ^a   Christen, A ^a   Efstathiadou, Z ^a   Johnston, D G ^a   Godsland, I F ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Impaired glucose homeostasis; Insulin secretion; Insulin sensitivity; Risk factors; Weight loss

Indexed keywords

INSULIN; LIVER ENZYME;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DISEASE MARKER; ENZYME ACTIVITY; FOLLOW UP; GLUCOSE HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; ORAL GLUCOSE TOLERANCE TEST; REGRESSION ANALYSIS; RISK FACTOR;

BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; RISK FACTORS;

EID: 35448989456     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02225.x     Document Type: Article

References (19)

1. Knowler WC, Pettitt DJ, Savage PJ, Bennett PH. Diabetes incidence in Pima Indians: contribution of obesity and parental diabetes. Am J Epidemiol 1981 113 : 144 156.
2. Ferrannini E, Nannipieri M, Williams K, Gonzales C, Haffner SM, Stern MP. Mode of onset of type 2 diabetes from normal or impaired glucose tolerance. Diabetes 2004 53 : 160 165.
3. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet 1989 17 : 1356 1359.
4. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999 104 : 787 794.
5. Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes 2003 52 : 1475 1484.
6. Osei K, Rhinesmith S, Gaillard T, Schuster D. Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention. Diabetes Care 2004 27 : 1439 1446.
7. Lyssenko V, Almgren P, Anevski D, Perfekt R, Lahti K, Nissen M et al. Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes 2005 54 : 166 174.
8. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. J Am Med Assoc 2001 286 : 327 334.
9. Wellen KE, Hotamisligil GS. Inflammation, stress and diabetes. J Clin Invest 2005 115 : 1111 1119.
10. Perry IJ, Wannamethee SG, Shaper AG. Prospective study of γ-glutamytransferase and risk of NIDDM. Diabetes Care 1998 21 : 232 237.
11. Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RBJ, Kempf J et al. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2004 53 : 2623 2632.
12. Godsland IF, Leyva F, Worthington M, Walton C, Stevenson JC. Associations of smoking, alcohol and physical activity with risk factors for coronary heart disease and diabetes in the first follow-up cohort of the HDDRISC Study (HDDRISC-1). J Intern Med 1998 244 : 33 41.
13. Jeffs JA, Godsland IF, Johnston DG. Less than 50% of variation in HDL cholesterol between and within individuals is explained by established predictors. Atherosclerosis 2006 184 : 178 187.
14. American Diabetes Association. Follow-up report on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003 26 : 3160 3167.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 : 412 419.
16. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999 22 : 1462 1470.
17. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 1993 329 : 1988 1992.
18. Haffner SM, Miettinen H, Gaskill SP, Stern MP. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 1995 44 : 1386 1391.
19. Festa A, Williams K, D'Agostino RJ, Wagenknecht LE, Haffner SM. The natural course of β-cell function in non-diabetic and diabetic individuals. The Insulin Resistance Atherosclerosis Study. Diabetes 2006 55 : 1114 1120.